Recombinant Human KLK13 (C-6His)

Recombinant Human KLK13 (C-6His)

Size1:10μg price1:$168
Size2:50μg price2:$465
Size3:500μg price3:$2350
SKU: PHH1032 Category: Target Proteins Tags: ,

Datasheet

Name

Recombinant Human KLK13 (C-6His)

Purity

Greater than 95% as determined by reducing SDS-PAGE

Endotoxin level

<1 EU/µg as determined by LAL test.

Construction

Recombinant Human Kallikrein 13 is produced by our Mammalian expression system and the target gene encoding Gly17-Ile262 is expressed with a 6His tag at the C-terminus.

Accession #

Q9UKR3

Host

Human Cells

Species

Human

Predicted Molecular Mass

28.03 KDa

Buffer

Supplied as a 0.2 μm filtered solution of 20mM MES, 150mM NaCl, 10% Glycerol, pH 5.5.

Form

Liquid

Shipping

The product is shipped on dry ice/polar packs.Upon receipt, store it immediately at the temperature listed below.

Stability&Storage

Store at ≤-70°C, stable for 6 months after receipt.Store at ≤-70°C, stable for 3 months under sterile conditions after opening. Please minimize freeze-thaw cycles.

 

 

 

Alternative Names

Kallikrein-13; Kallikrein-Like Protein 4; KLK-L4; KLK13; KLKL4

 

Background

Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many Kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. This gene is one of the fifteen Kallikrein subfamily members located in a cluster on chromosome 19. Its encoded protein is secreted and may play a role in suppression of tumorigenesis in breast and prostate cancers. Alternate splicing of this gene results in multiple transcript variants encoding the same protein.

 

Note

For Research Use Only , Not for Diagnostic Use.